Enrollment of Older Patients in Cancer Treatment Trials in Canada: Why is Age a Barrier?
- 15 April 2003
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (8), 1618-1623
- https://doi.org/10.1200/jco.2003.12.044
Abstract
Purpose: To evaluate the enrollment of older patients (≥ 65 years) in Canadian cancer treatment trials and compare accrual of older patients in Canada and the United States. Patients and Methods: A retrospective analysis of the number of older patients enrolled in National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) treatment trials between 1993 and 1996 was performed. These rates were compared with the corresponding rates in the general population of patients who were ≥ 65 years old and had cancer, obtained from Statistics Canada, and those published by the Southwest Oncology Group (SWOG) in the United States. Results: Between 1993 and 1996, 4,174 patients were enrolled onto 69 NCIC CTG trials of 16 tumor types. Older patients accounted for 22% of trial enrollees, compared with 58% of the Canadian population with cancer. This discrepancy existed in all cancer types except for multiple myeloma. The percentages of older patients enrolled were also analyzed by study type: 15% in adjuvant trials, 25% in metastatic trials, 29% in investigational new drug trials, 24% in phase I trials, and 21% in supportive care trials. The overall proportion of older patients enrolled onto Canadian trials (22%) was slightly lower than that in SWOG trials (25%). Conclusion: Age remains a barrier for accrual onto cancer treatment trials, even when reimbursement is not an issue. Strategies to overcome this barrier, including the implementation of trials specifically tailored to patients aged ≥ 65 years, are prudent in light of our aging population.Keywords
This publication has 33 references indexed in Scilit:
- Evaluating the Financial Impact of Clinical Trials in Oncology: Results From a Pilot Study From the Association of American Cancer Institutes/Northwestern University Clinical Trials Costs and Charges ProjectJournal of Clinical Oncology, 2000
- Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment TrialsThe New England Journal of Medicine, 1999
- Cancer Patient Care in Clinical Trials Sponsored by the National Cancer Institute: What Does It Cost?JNCI Journal of the National Cancer Institute, 1999
- Determinants of Survival in Older Cancer PatientsJNCI Journal of the National Cancer Institute, 1996
- Patterns of breast cancer care in the elderlyCancer, 1996
- Representation of older patients in cancer treatment trialsCancer, 1994
- The influence of age on treatment choice and survival of elderly breast cancer patients in south-eastern Netherlands: A population-based studyEuropean Journal of Cancer, 1992
- Cancer Treatment ProtocolsArchives of Internal Medicine, 1988
- Accrual of patients into a multihospital cancer clinical trial and its implications on planning future studiesAmerican Journal of Clinical Oncology, 1984
- Cooperative groups and community hospitals. Measurement of impact in the community hospitalsCancer, 1983